CBD.NZ
Cannasouth Ltd
Price:  
0.10 
NZD
Volume:  
204,091.00
New Zealand | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CBD.NZ WACC - Weighted Average Cost of Capital

The WACC of Cannasouth Ltd (CBD.NZ) is 6.1%.

The Cost of Equity of Cannasouth Ltd (CBD.NZ) is 6.50%.
The Cost of Debt of Cannasouth Ltd (CBD.NZ) is 4.45%.

Range Selected
Cost of equity 5.40% - 7.60% 6.50%
Tax rate 28.00% - 28.00% 28.00%
Cost of debt 4.00% - 4.90% 4.45%
WACC 5.0% - 7.1% 6.1%
WACC

CBD.NZ WACC calculation

Category Low High
Long-term bond rate 4.3% 4.8%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.2 0.37
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 7.60%
Tax rate 28.00% 28.00%
Debt/Equity ratio 0.15 0.15
Cost of debt 4.00% 4.90%
After-tax WACC 5.0% 7.1%
Selected WACC 6.1%

CBD.NZ's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CBD.NZ:

cost_of_equity (6.50%) = risk_free_rate (4.55%) + equity_risk_premium (5.60%) * adjusted_beta (0.2) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.